Dr Duncan McLaren

Consultant Clinical Oncologist

MBBS, BSc (First Class Hons), FRCR, FRCP(Ed)


Specialises in

I am a specialist in Genito-Urinary Oncology and run a large practice offering non-surgical treatment with radiotherapy and chemotherapy for urological cancer patients. I have a particular interest in prostate brachytherapy (seeds) and dose escalated hypo-fractionated radiotherapy.

Edinburgh was the first Scottish Centre to offer prostate brachytherapy in 2001. State-of-the-art volumetric arc based radiotherapy (VMAT) and intensity modulated radiotherapy (IMRT) for prostate cancer are routinely available. In addition, the prostate stereotactic ablative radiotherapy (SBRT) service has been up and running since 2017.

For patients with bladder cancer neo-adjuvant chemotherapy is routinely used before surgery or concurrent chemo-radiotherapy. I am a co-investigator on the UK RAIDER trial investigating dose escalated IMRT for bladder cancer in addition.

Chemotherapy and new targeted therapy drugs are an important area of disease management. I have extensive experience in the use of Taxotere chemotherapy Abiraterone, Enzalutamide and Alpharadin for example in prostate cancer and Sunitinib, Pazopanib and Axitinib for renal cancer. I ensure early access to newly licensed effective drugs and entry into clinical trials for new treatments as team leader for Urological cancer trials with in the SE of Scotland.

I also have a very exciting on-going collaboration with the University of Edinburgh Department of Electrical Engineering, Royal Dick Veterinary School and Edinburgh Cancer Research Centre to develop a micro chip system to provide real time measurements of tumour oxygen levels. In time I hope to implant this device directly into tumours within the prostate and individualise radiotherapy treatments by timing radiotherapy delivery with peak oxygen levels within the tumour. In addition I am co-investigator on a biomarker of radiation sensitivity project as part of a large European grant and ongoing research with oncology physics to identify tumours more accurately for targeting with radiotherapy via novel imaging processing techniques.

Read more...

Treatment information

Some of the principal treatments carried out by Dr Duncan McLaren at Spire include:

Other treatments

  • Bladder cancer
  • Kidney cancer
  • Prostate cancer
  • Radiotherapy

Get in touch

19214
True
consultant

Marketing Information

Spire would like to provide you with marketing information about products and services offered by Spire and by selected third-party partners. If you do not consent for us to process your personal data for marketing activities, we will still be able to contact you about your enquiry.

We may contact you by email, SMS or phone about your enquiry. If we try to contact you by phone (mobile and/or landline) and you are not available, we may leave you a voicemail message. We may also use your details to contact you about patient surveys we use for improving our service or monitoring outcomes, which are not a form of marketing.

Additional information

Clinical interests

Oncology
Bladder cancer
Kidney cancer
Prostate cancer

Specialist in prostate, bladder and kidney cancer. Specialist treatment with radiotherapy and chemotherapy. Prostate 'seed' Brachytherapy. Access to new drug treatments in clinical trials.

Qualification and professional memberships

Professional memberships

Royal College of Radiologists (London)

Royal College of Physicians (Edin)

Former member of National Cancer Research Network Clinical Trials (NCRN) group for Prostate Cancer and Bladder Cancer

British Urological Group

South East Scotland GU Cancer Group (SCAN)

UK and Ireland Brachytherapy Users Group

Chair of the Edinburgh Radiation Research Collaborative

Research and publications

Lead clinician for radiotherapy research at the Edinburgh Cancer CentreLead clinician for GU Chemotherapy and Radiation Trials at the Edinburgh Cancer Centre. Collaborative research with Edinburgh University Engineering Department, Royal Dick Veterinary School and Edinburgh Cancer Research Centre to develop a lab on a chip system to measure prostate tumour hypoxia and optimise radiotherapy delivery.  

Collaborative research with the University of Edinburgh Oncology Physics unit to develop image processing techniques to localise the prostate tumour within the prostate for focal therapy or a radiation dose boost.  Toxi-triage co investigator to look at measuring biomarkers of radiation exposure.

Current NHS posts

Consultant Clinical Oncologist Edinburgh Cancer Centre.

Honorary Senior Lecturer University of Edinburgh.

Personal profile

I undertook undergraduate training at St Mary's Hospital Medical School in London from 1983-1989. I also undertook an intercalated BSc in Clinical Science and gained First Class Honours. I did my General Medical training at Queens University Hospital Nottingham and specialist cancer training at Velindre Cancer Hospital Cardiff. I then did a Clinical Fellowship specialising in GU oncology at the British Columbia Cancer Agency, Vancouver.

I was appointed as a Consultant Clinical Oncologist and Honorary Clinical Senior Lecturer at the Edinburgh Cancer Centre in 1998. I am married with two children, we have a pet dog and stay in Edinburgh. I enjoy playing as much golf and supporting as much rugby as time allows.

Contact information

Telephone 0131 334 0363
Email hillparkmedicalservices@outlook.com
Private secretary 07514 232839
Private secretary email hillparkmedicalservices@outlook.com